Scientists from Pacific Biosciences of California, Inc. (NASDAQ: PACB) and Harvard Medical School have successfully employed single molecule, real-time (SMRT™) DNA sequencing technology to rapidly characterize the pathogen responsible for the recent deadly cholera epidemic in Haiti. Published online Thursday in the New England Journal of Medicine, the results provide the first whole...
PRESS RELEASES
Pre-2011
December 9, 2010
October 27, 2010
Pacific Biosciences of California, Inc. (NASDAQ:PACB), developer of single molecule, real-time (SMRT™) technology for biological analysis, announced today the pricing of its initial public offering of 12,500,000 shares of its common stock at $16.00 per share.
September 1, 2010
Pacific Biosciences today announced that on August 27, 2010, the Company was named as a defendant in a complaint filed by Helicos Biosciences Corporation in the United States District Court...
August 3, 2010
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced it has expanded its...
July 14, 2010
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule...
July 9, 2010
As part of its commitment to introducing third generation DNA sequencing technology to the market, Pacific Biosciences today announced the launch of a software developer’s network – the PacBio DevNet...
June 17, 2010
Gen-Probe Incorporated (NASDAQ: GPRO) and Pacific Biosciences announced today that Gen-Probe has made a $50 million strategic investment in Pacific Biosciences, a private sequencing company.
March 3, 2010
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced the appointment of Susan...
February 23, 2010
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced the 10 institutions...
February 16, 2010
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced the launch of a partner...
December 3, 2009
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced that it has been named...
October 19, 2009
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, announced today that Evan Eichler...
October 8, 2009
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced that it has received...
September 21, 2009
Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today provided a number of updates...
August 12, 2009
Pacific Biosciences, a private company pioneering the development of a transformative DNA sequencing technology, announced today it has raised an additional $68 million in financing...
May 28, 2009
Pacific Biosciences, a private company developing third-generation DNA sequencing technology, today announced that leading genetic scientist Eric E. Schadt, Ph.D. has joined the company...
March 25, 2009
Pacific Biosciences, a private company developing third-generation single molecule DNA sequencing technology, announced today that it has been named the Senior Partner in a patent interference...
November 20, 2008
Dr. Elaine Mardis Joins Pacific Biosciences Scientific Advisory Board. Company Also Announces Additional $20 Million Financing From New Investor...
July 14, 2008
Pacific Biosciences announced today that it has secured $100 million in a Series E private equity financing round. The proceeds will be used to fund the commercial development of the company's innovative...
May 27, 2008
Menlo Park, CA and Lincoln, NE- May 27, 2008- Pacific Biosciences announced today that is has acquired "sequencing by incorporation" technology from LI-COR Biosciences of Lincoln Nebraska...
© 2010 - 2013, Pacific Biosciences of California, Inc. All rights reserved